$8.69
-0.22-2.47%
At close: Aug 10, 5:00 PM EST
$8.69
N/A
After Hours: 4:00 PM EST
Puma Biotechnology Inc Earnings Estimates
PBYINASDAQ
Earnings: Q2 2026 Earnings were released on Thu Aug 6th, after the market close
Conference Call: The most recent conference call started at 4:30 PM, 4 days agoClick to view the webcast
Puma Biotechnology Earnings Estimates, EPS & Revenue | NASDAQ:PBYI
Puma Biotechnology (PBYI) is scheduled to report Q3 earnings on November 5, 2026. Analysts estimate EPS of $0.12 and quarterly revenue of $57.5M.
In the most recent quarter (Q2), Puma Biotechnology reported EPS of $0.19, beating estimates of $0.07 by 1.71%. Revenue came in at $53.6M, exceeding the estimate of $53.07M by 0.01%.
Puma Biotechnology has beaten EPS estimates in 8 consecutive quarters.
Over the last 4 quarters, Puma Biotechnology has averaged an EPS surprise of 1.11% and a revenue surprise of 0.07%.
Earnings Date
Nov 5
EPS Estimate
$0.120
Quarterly Revenue Estimate
$57.5M
Annual Revenue
$231.24M
as of Jun 30
Puma Biotechnology Earnings History
Analyze the earnings history of Puma Biotechnology using advanced sorting and filters.
Puma Biotechnology (PBYI) Earnings Per Share
The chart below shows Puma Biotechnology's reported EPS compared to analyst estimates over recent quarters.
Puma Biotechnology (PBYI) Revenue
The chart below shows Puma Biotechnology's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Puma Biotechnology (NASDAQ:PBYI) reporting earnings?
Puma Biotechnology (PBYI) is scheduled to report earnings on November 5, 2026. The last reported earnings were for reported on August 6, 2026 for Q2.
What were the latest earnings per share (EPS) for Puma Biotechnology (NASDAQ:PBYI)?
The Actual EPS was $0.19, which beat the estimate of $0.07.
What were Puma Biotechnology’s (NASDAQ:PBYI) revenues?
The Actual Revenue was $53.6M, which beat the estimate of $53.07M.
